Hydroxychloroquine for Primary Progressive Multiple Sclerosis.

Marcus Werner KochSharanjit KaurKayla SageJanet KimMyriam Levesque-RoyGraziela CerchiaroVoon Wee YongGary R CutterLuanne M Metz

Published in: Annals of neurology (2021)

HCQ treatment was associated with reduced disability worsening in people with PPMS. HCQ is a promising treatment candidate in PPMS and should be investigated further in randomized controlled clinical trials. ANN NEUROL 2021;90:940-948.

Keyphrases

multiple sclerosis
clinical trial
open label
combination therapy
mass spectrometry
placebo controlled
smoking cessation